AJP - Heart Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 293: H2140-H2147, 2007. First published July 27, 2007; doi:10.1152/ajpheart.00390.2007
0363-6135/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/4/H2140    most recent
00390.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vinci, M. C.
Right arrow Articles by Parenti, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vinci, M. C.
Right arrow Articles by Parenti, A.

Trophic effects induced by {alpha}1D-adrenoceptors on endothelial cells are potentiated by hypoxia

Maria Cristina Vinci, Lydia Bellik, Sandra Filippi, Fabrizio Ledda, and Astrid Parenti

Laboratory of Vascular Pharmacology, Department of Preclinical and Clinical Pharmacology, University of Florence, Florence, Italy

Submitted 29 March 2007 ; accepted in final form 26 July 2007

Catecholamines have been shown to be involved in vascular remodeling through the stimulation of {alpha}1-adrenoceptors ({alpha}1-ARs). Recently, it has been demonstrated that catecholamines can stimulate angiogenesis in pathological conditions, even if the mechanisms and the AR subtypes involved still remain unclear. We investigated the influence of hypoxia (3% O2) on the ability of picomolar concentrations of phenylephrine (PHE), which are unable to induce any vascular contraction, to induce a trophic effect in human endothelial cells through stimulation of the {alpha}1D-subtype ARs. PHE, at picomolar concentrations, significantly promoted pseudocapillary formation from fragments of human mature vessels in vitro. Exposure to hypoxia significantly potentiated this effect, which was inhibited by the selective {alpha}1D-AR antagonist BMY-7378 and by the nitric oxide synthase inhibitor L-NAME, suggesting that {alpha}1D-ARs were involved in this effect through activation of the nitric oxide pathway. Proliferation and migration of HUVEC were also affected by picomolar PHE concentrations. Again, these effects were significantly potentiated in cells exposed to hypoxia and were inhibited by BMY-7378 and by NG-nitro-L-arginine methyl ester. Conversely, the {alpha}1A-AR-selective antagonist (S)-(+)-niguldipine hydrochloride and the {alpha}1B-AR antagonist chloroethylclonidine dihydrochloride did not modify endothelial cell migration and proliferation in response to PHE. These results demonstrate that the stimulation of {alpha}1D-ARs, triggered by picomolar PHE concentrations devoid of any contractile vascular effects, induces a proangiogenic phenotype in human endothelial cells that is enhanced in a hypoxic environment. The role of {alpha}1D-ARs may become more prominent in the adaptive responses to hypoxic vasculature injury.

vascular remodeling; low oxygen tension; endothelial cell growth and migration; catecholamines; nitric oxide



Address for reprint requests and other correspondence: A. Parenti, Dept. of Preclinical and Clinical Pharmacology, Univ. of Florence, Viale G. Pieraccini, 6, 50139 Florence, Italy (e-mail: astrid.parenti{at}unifi.it)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.